Koyfin Home > Directory > Health Care > Akebia Therapeutics > Enterprise Value

Akebia Therapeutics Enterprise Value Chart (AKBA)

Akebia Therapeutics annual/quarterly Enterprise Value from 2014 to 2020.
  • Akebia Therapeutics Enterprise Value for the quarter ending September 09, 2020 was $164m a -31.53% decrease of -52m year over year
  • Akebia Therapeutics Enterprise Value for the last 12 months ending September 09, 2020 was $164m a -31.53% decrease of -52m year over year
  • Akebia Therapeutics Annual Enterprise Value for 2020 was $164m a -7.01% decrease of -11m from 2019
  • Akebia Therapeutics Annual Enterprise Value for 2020 was $175m a -20.46% decrease of -36m from 2019
  • Akebia Therapeutics Annual Enterprise Value for 2020 was $211m a -2.04% decrease of -4m from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
View Chart On Koyfin

Quarterly AKBA Enterprise Value Data

09/2020$164m
09/2020$175m
09/2020$211m
09/2020$215m
09/2020$212m
09/2020$234m
09/2020$194m
09/2020$189m
09/2020$198m
09/2020$174m

Annual AKBA Enterprise Value Data

2020$164m
2020$175m
2020$211m
2020$215m
2020$212m
2020$234m
2020$194m
2020$189m
2020$198m
2020$174m